Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

548
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
548
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.0K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging mass cytometry reveals functional and immunological changes during type 1 diabetes progression in human pancreata.

Nature metabolism·2026
Same author

Role of genetic risk on progression to diabetes in children with acute pancreatitis.

medRxiv : the preprint server for health sciences·2026
Same author

Pathogen-specific immune responses might underlie divergent outcomes of coronavirus and influenza infection in the natural porcine host.

Communications biology·2026
Same author

Aberrant immune regulation and enrichment of stem-like CD8<sup>+</sup> T cells in the pancreatic lymph node during type 1 diabetes development.

bioRxiv : the preprint server for biology·2026
Same author

Immune Intervention and Beta Cell Replacement Therapies in T1D.

Diabetes technology & therapeutics·2026
Same author

Fast Value Tracking for Deep Reinforcement Learning.

... International Conference on Learning Representations·2026

Related Experiment Video

Updated: Mar 8, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

16.2K

Serum Trypsinogen Levels in Type 1 Diabetes.

Xia Li1,2, Martha Campbell-Thompson2, Clive H Wasserfall2

  • 1Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Metabolic Syndrome Research Center, Central South University, National Clinical Research Center for Metabolic Diseases, Changsha, China.

Diabetes Care
|January 25, 2017
PubMed
Summary
This summary is machine-generated.

Serum trypsinogen levels are significantly lower in individuals with type 1 diabetes, indicating potential pancreatic exocrine dysfunction. This finding supports trypsinogen as a biomarker for type 1 diabetes progression.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.1K
Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

11.3K

Related Experiment Videos

Last Updated: Mar 8, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

16.2K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

3.1K
Extraction of Tissue Antigens for Functional Assays
08:32

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

11.3K

Area of Science:

  • Endocrinology
  • Gastroenterology
  • Metabolic disorders

Background:

  • Type 1 diabetes is associated with pancreatic atrophy and exocrine abnormalities.
  • Serum trypsinogen is a recognized indicator of pancreatic exocrine function.

Purpose of the Study:

  • To investigate serum trypsinogen levels in individuals with type 1 diabetes and related conditions.
  • To assess if trypsinogen levels are reduced in pre-type 1 diabetes and type 1 diabetes.

Main Methods:

  • Serum trypsinogen levels were measured in 100 patients with type 1 diabetes, 99 autoantibody-positive (AAb+) subjects, 87 AAb-negative (AAb-) control subjects, 91 AAb- relatives, and 18 patients with type 2 diabetes.
  • Statistical analyses, including multivariate analysis, were performed to compare trypsinogen levels across groups, adjusting for age and BMI.

Main Results:

  • Trypsinogen levels increased with age in control subjects.
  • Significantly lower trypsinogen levels were observed in new-onset and established type 1 diabetes patients compared to AAb- controls, AAb- relatives, AAb+ subjects, and type 2 diabetes patients.
  • Multivariate analysis confirmed reduced trypsinogen in multiple-AAb+ subjects and type 1 diabetes patients compared to AAb- subjects and single-AAb+ subjects.

Conclusions:

  • The study supports a connection between pancreatic endocrine and exocrine dysfunction in type 1 diabetes.
  • Further longitudinal studies are recommended to validate trypsinogen as a predictive biomarker for type 1 diabetes progression.